IPG Photonics Announces Sale of its Russian Operations
Rhea-AI Summary
IPG Photonics (NASDAQ: IPGP) has sold its entire interest in its Russian subsidiary, IRE-Polus, to a group led by Softline Projects and current IRE-Polus management for $51 million before fees. This sale marks IPG's complete exit from Russia following sanctions imposed after the Ukraine war. The company expects a $5 million reduction in Q3 revenue and estimates total charges of $195-$210 million related to the transaction.
CEO Dr. Mark Gitin highlighted the company's resilience in transitioning manufacturing operations without impacting customers, leveraging global capabilities in Germany, the US, Italy, and Poland. IPG is now focusing on optimizing operations for improved productivity.
Positive
- Successful sale of Russian operations for $51 million
- Complete exit from Russia, reducing geopolitical risk
- Demonstrated resilience by transitioning manufacturing without customer impact
- Expanded production capabilities in Germany, US, Italy, and Poland
Negative
- Expected $5 million reduction in Q3 revenue
- Estimated charges of $195-$210 million related to the sale
- Loss of Russian market and associated revenue stream
News Market Reaction
On the day this news was published, IPGP declined 1.20%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
MARLBOROUGH, Mass., Aug. 29, 2024 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (NASDAQ: IPGP) today announced that it has sold its entire interest in its Russian subsidiary, IRE-Polus. The purchaser is a group led by Softline Projects LLC and current management of IRE-Polus. The sale marks the finalization of IPG’s exit from all facilities in Russia, following imposed sanctions on trade after the start of the war with Ukraine. The proceeds from the transaction are
“Our team executed flawlessly to transition our manufacturing operations after the war’s outbreak without any impact to our customers. Our ability to respond to adverse events out of our control highlights the resilience of the company as we were able to lean on our global manufacturing capabilities to increase production in Germany, the United States and Italy and start production in Poland,” said Dr. Mark Gitin, IPG Photonics’ Chief Executive Officer. “Today, with the sale of our Russian operations now behind us, we are focusing on optimizing our operations to drive improved productivity.”
The Company expects that the sale will reduce third quarter revenue as compared to previously provided guidance by approximately
Contact
Eugene Fedotoff
Senior Director, Investor Relations
IPG Photonics Corporation
508-597-4713
efedotoff@ipgphotonics.com
About IPG Photonics Corporation
IPG Photonics Corporation is the leader in high-power fiber lasers and amplifiers used primarily in materials processing and other diverse applications. The Company’s mission is to develop innovative laser solutions making the world a better place. IPG accomplishes this mission by delivering superior performance, reliability and usability at a lower total cost of ownership compared with other types of lasers and non-laser tools, allowing end users to increase productivity and decrease costs. IPG is headquartered in Marlborough, Massachusetts and has more than 30 facilities worldwide. For more information, visit www.ipgphotonics.com.
Safe Harbor Statement
Information and statements provided by IPG and its employees, including statements in this press release, that relate to future plans, events or performance are forward-looking statements. These statements involve risks and uncertainties. Any statements in this press release that are not statements of historical fact are forward-looking statements. These include but are not limited to the reduction in third quarter revenue as compared to previously provided guidance, the impairment charge related to the carrying value of net assets of IRE-Polus and the charge related to the cumulative translation adjustment component of other comprehensive income that is included in shareholders equity. Factors that could cause actual results to differ materially include risks and uncertainties, including risks associated with the strength or weakness of the business conditions in industries and geographic markets that IPG serves, particularly the effect of downturns in the markets IPG serves; uncertainties and adverse changes in the general economic conditions of markets; inability to manage risks associated with international customers and operations; changes in trade controls and trade policies; IPG's ability to penetrate new applications for fiber lasers and increase market share; the rate of acceptance and penetration of IPG's products; foreign currency fluctuations; high levels of fixed costs from IPG's vertical integration; the appropriateness of IPG's manufacturing capacity for the level of demand; competitive factors, including declining average selling prices; the effect of acquisitions and investments; inventory write-downs; asset impairment charges; intellectual property infringement claims and litigation; interruption in supply of key components; manufacturing risks; government regulations and trade sanctions; and other risks identified in IPG's SEC filings. Readers are encouraged to refer to the risk factors described in IPG's Annual Report on Form 10-K (filed with the SEC on February 21, 2024) and IPG's reports filed with the SEC, as applicable. Actual results, events and performance may differ materially. Readers are cautioned not to rely on the forward-looking statements, which speak only as of the date hereof. IPG undertakes no obligation to update the forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
FAQ
What is the value of IPG Photonics' (IPGP) sale of its Russian operations?
How will the sale of Russian operations affect IPG Photonics' (IPGP) Q3 2024 revenue?
What charges does IPG Photonics (IPGP) expect to record due to the sale of its Russian subsidiary?
Who purchased IPG Photonics' (IPGP) Russian subsidiary, IRE-Polus?
